Huntington National Bank lifted its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 66.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,260 shares of the medical instruments supplier’s stock after purchasing an additional 501 shares during the quarter. Huntington National Bank’s holdings in DENTSPLY SIRONA were worth $71,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. First Trust Advisors LP raised its position in DENTSPLY SIRONA by 203.9% during the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock valued at $4,517,000 after acquiring an additional 61,111 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 39.9% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock valued at $9,157,000 after purchasing an additional 52,645 shares during the period. Cubist Systematic Strategies LLC grew its holdings in DENTSPLY SIRONA by 218.8% in the second quarter. Cubist Systematic Strategies LLC now owns 26,826 shares of the medical instruments supplier’s stock valued at $1,566,000 after purchasing an additional 18,411 shares during the period. UBS Asset Management Americas Inc. grew its holdings in DENTSPLY SIRONA by 26.6% in the second quarter. UBS Asset Management Americas Inc. now owns 976,483 shares of the medical instruments supplier’s stock valued at $56,988,000 after purchasing an additional 205,449 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its holdings in DENTSPLY SIRONA by 1.6% in the second quarter. Price T Rowe Associates Inc. MD now owns 5,471,623 shares of the medical instruments supplier’s stock valued at $319,324,000 after purchasing an additional 87,294 shares during the period. Hedge funds and other institutional investors own 94.38% of the company’s stock.
Several brokerages have commented on XRAY. ValuEngine lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. lowered DENTSPLY SIRONA from an “overweight” rating to a “neutral” rating and set a $65.00 price objective on the stock. in a report on Wednesday, December 11th. They noted that the move was a valuation call. Barclays reaffirmed a “hold” rating and issued a $64.00 price target on shares of DENTSPLY SIRONA in a research note on Sunday, January 19th. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday. Finally, HC Wainwright reaffirmed a “hold” rating and issued a $60.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company’s stock. DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus price target of $58.27.
Shares of NASDAQ:XRAY opened at $59.66 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.08 and a quick ratio of 1.39. The business’s 50 day moving average price is $57.66 and its 200-day moving average price is $55.09. The firm has a market capitalization of $13.42 billion, a PE ratio of 82.86, a P/E/G ratio of 1.89 and a beta of 0.94. DENTSPLY SIRONA Inc has a 1 year low of $40.26 and a 1 year high of $60.87.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.07. The firm had revenue of $962.10 million for the quarter, compared to analyst estimates of $940.38 million. DENTSPLY SIRONA had a return on equity of 10.08% and a net margin of 4.08%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 earnings per share. As a group, analysts expect that DENTSPLY SIRONA Inc will post 2.46 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date was Thursday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 19.90%.
In other DENTSPLY SIRONA news, Director Michael C. Alfano sold 10,665 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $56.27, for a total transaction of $600,119.55. Following the transaction, the director now owns 15,153 shares of the company’s stock, valued at $852,659.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.62% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: How Investors Can Profit from Options Trading
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.